Effectiveness of inactivated and mRNA COVID-19 vaccines on sperm parameters

Abstract

Objective: The mRNA SARS-CoV-2 vaccine has been shown to have no adverse effects on semen parameters. However, it is yet unknown whether the inactivated vaccinations have the same effect. Thus, our objective was to evaluate the parameters of sperm prior and following the administration of mRNA and inactivated COVID-19 vaccinations. Methods: In this study, the sperm quality was evaluated both before and after receiving the COVID-19 mRNA and inactivated vaccines. Of the participants, 28 received two doses of CoronaVac vaccine and 152 received two doses of mRNA BNT162b2 mRNA vaccine (Pfizer-BioNTech). Semen analyses were repeated 72 (57-145) days after the same individuals had received their second dose of COVID-19 vaccination. Results: No significant differences were found in the parameters of sperm before and after administration of two doses of BNT162b2 vaccine. Prior to and following administration of the two doses of the inactivated vaccine, there was no appreciable variation in the volume of semen, sperm concentration, progressive motility, total motility, immotility, or morphologically normal sperm features. Following CoronaVac vaccination before and after two doses, only the total sperm count was shown to statistically decrease (p=0.03). Conclusion: As a result, while there was no significant difference in the sperm parameters of the mRNA vaccine, it was determined that there was a statistical decrease in the total sperm count before and after two doses of CoronaVac vaccine. Since the semen volume of all patients is within normal limits, the first issue to be used here as a number is sperm per ml, which is important in terms of infertility, is the number.

Keywords

• Inactivated vaccine
• mRNA vaccine
• male fertility
• sperm parameters

References

1. 1.Bahçe YG, Acer Ö, Özüdoğru O. Evaluation ofbacterial agents isolated from endotracheal aspiratecultures of Covid-19 general intensive care patientsand their antibiotic resistance profiles compared to pre-pandemic conditions. Microb Pathog. 2022; 105409.
2. 2.Zhu N, Zhang D, Wang W, et al. A NovelCoronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382: 727-33.
3. 3.Lifshitz D, Haas J, Lebovitz O, et al. Does mRNASARS-CoV-2 vaccine detrimentally affect malefertility, as reflected by semen analysis? ReprodBiomed Online. 2022; 44: 145-9.
4. 4.Ma X, Guan C, Chen R, et al. Pathological andmolecular examinations of postmortem testisbiopsies reveal SARS-CoV-2 infection in the testisand spermatogenesis damage in COVID-19 patients.Cell Mol Immunol. 2021; 18: 487-9.
5. 5.Wang Z, Xu X. scRNA-seq profiling of human testes reveals the presence of the ACE2 receptor, a targetfor SARS-CoV-2 infection in spermatogonia, Leydigand Sertoli cells. Cells. 2020; 9: 920.
6. 6.Salonia A, Pontillo M, Capogrosso P, et al.Testosterone in males with COVID‐19: A 7‐monthcohort study. Andrology. 2022; 10: 34-41.
7. 7.Zhu H, Wang X, Zhang F, et al. Evaluation ofinactivated COVID-19 vaccine on semen parametersin reproductive-age males: a retrospective cohortstudy. Asian J Androl. 2022; 24(5): 441.
8. 8.Barda S, Laskov I, Grisaru D, et al. The impact ofCOVID‐19 vaccine on sperm quality. Int J GynecolObstet. 2022; 158: 116–20.

9. 9.Navarra A, Albani E, Castellano S, et al.Coronavirus Disease-19 Infection: Implications onMale Fertility and Reproduction. Front Physiol.2020; 11: 574761.
10. 10.Li H, Xiao X, Zhang J, et al. Impairedspermatogenesis in COVID-19 patients.EClinicalMedicine. 2020; 28: 100604.
11. 11.Holtmann N, Edimiris P, Andree M, et al.Assessment of SARS-CoV-2 in human semen—acohort study. Fertil Steril. 2020; 114: 233-8.
12. 12. Guo T-H, Sang M-Y, Bai S, et al. Semen parameters in men recovered from COVID-19. Asian J Androl.2021; 23: 479.
13. 13.Temiz MZ, Dincer MM, Hacibey I, et al.Investigation of SARS‐CoV‐2 in semen samples and the effects of COVID‐19 on male sexual health by using semen analysis and serum male hormone profile: A cross‐sectional, pilot study. Andrologia. 2021; 53: e13912.
14. 14.Özüdoğru O, Acer Ö, Genç Bahçe Y. Risks ofcatching COVID‐19 according to vaccination statusof healthcare workers during the SARS‐CoV‐2 Deltavariant dominant period and their clinicalcharacteristics. J Med Virol. 2022; 94: 3706–3713.
15. 15.Gonzalez DC, Nassau DE, Khodamoradi K, et al.Sperm parameters before and after COVID-19mRNA vaccination. JAMA. 2021; 326: 273-4.
16. 16.Freeman D, Loe BS, Chadwick A, et al. COVID-19vaccine hesitancy in the UK: the Oxford coronavirusexplanations, attitudes, and narratives survey(Oceans) II. Psychol Med. 2020; 1-15.
17. 17.Salonia A, Pontillo M, Capogrosso P, et al.Severely low testosterone in males with COVID‐19:A case‐control study. Andrology. 2021; 9: 1043-52.
18. 18.Reschini M, Pagliardini L, Boeri L, et al. COVID-19vaccination does not affect reproductive healthparameters in men. Front. Public Health. 2022; 10:839967
19. 19.Guo L, Zhao S, Li W, et al. Absence of SARS‐CoV‐2in semen of a COVID‐19 patient cohort. Andrology.2021; 9: 42-7.
20. 20.He Y, Wang J, Ren J, et al. Effect of COVID-19 onmale reproductive system–a systematic review.Front Endocrinol. 2021; 12: 677701.
21. 21.Kayaaslan B, Korukluoglu G, Hasanoglu I, et al.Investigation of SARS-CoV-2 in semen of patients inthe acute stage of COVID-19 infection. Urol Int. 2020; 104: 678-83.
22. 22. Song C, Wang Y, Li W, et al. Absence of 2019 novel coronavirus in semen and testes of COVID-19patients. Biol Reprod. 2020; 103: 4-6.
23. 23. Chen F, Zhu S, Dai Z, et al. Effects of COVID-19 and mRNA vaccines on human fertility. Hum Reprod.2022; 37: 5-13.
24. 24.Safrai M, Herzberg S, Imbar T, et al. TheBNT162b2 mRNA Covid-19 vaccine does not impairsperm parameters. Reprod Biomed Online. 2022;44: 685-8.
25. 25.Orvieto R, Noach-Hirsh M, Segev-Zahav A, et al.Does mRNA SARS-CoV-2 vaccine influence patients'performance during IVF-ET cycle? Reprod BiolEndocrinol. 2021; 19: 1-4.
26. 26.Wang M, Yang Q, Zhu L, et al. InvestigatingImpacts of CoronaVac Vaccination in Males on InVitro Fertilization: A Propensity Score MatchedCohort Study. World J Mens Health. 2022; 40: 570-9.
27. 27.Gao Q, Bao L, Mao H, et al. Development of aninactivated vaccine candidate for SARS-CoV-2.Science. 2020; 369: 77-81.
28. 28.Tanriover MD, Doğanay HL, Akova M, et al.Efficacy and safety of an inactivated whole-virionSARS-CoV-2 vaccine (CoronaVac): interim results ofa double-blind, randomised, placebo-controlled,phase 3 trial in Turkey. Lancet. 2021; 398: 213-222.
29. 29.Bueno SM, Abarca K, González PA, et al. Safetyand immunogenicity of an inactivated severe acuterespiratory syndrome coronavirus 2 vaccine in asubgroup of healthy adults in chile. Clin Infect Dis.2022; 75: e792-e804.
30. 30.Xia W, Zhao J, Hu Y, et al. Investigate the effect ofCOVID‐19 inactivated vaccine on sperm parametersand embryo quality in in vitro fertilization.Andrologia. 2022; 54: e14483.